Cover Image
市場調查報告書

全球疫苗委託製造市場分析:各疫苗類型(弱毒化、惰性化、次單元、類毒素、DNA)、工作流程(下游、上游產業)、對象(人、動物)、地區 2018年∼2025年

Vaccine Contract Manufacturing Market Analysis Report By Vaccine Type (Attenuated, Inactivated, Subunit, Toxoid, DNA), By Workflow (Downstream, Upstream), By Application (Human, Veterinary), And Segment Forecasts, 2018 - 2025

出版商 Grand View Research, Inc. 商品編碼 614712
出版日期 內容資訊 英文 144 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球疫苗委託製造市場分析:各疫苗類型(弱毒化、惰性化、次單元、類毒素、DNA)、工作流程(下游、上游產業)、對象(人、動物)、地區 2018年∼2025年 Vaccine Contract Manufacturing Market Analysis Report By Vaccine Type (Attenuated, Inactivated, Subunit, Toxoid, DNA), By Workflow (Downstream, Upstream), By Application (Human, Veterinary), And Segment Forecasts, 2018 - 2025
出版日期: 2018年02月16日 內容資訊: 英文 144 Pages
簡介

全球疫苗委託製造市場,預計從2018年到2025年的調查期間中以9.3%的年複合成長率發展,到2025年成長到40億美元規模的市場。由於來自開發中國家及開發國的政府,及民間部門的疫苗開發的需求,這個市場預計今後數年將大幅度成長。

本報告提供全球疫苗委託製造市場相關調查,市場概要,各疫苗類型、工作流程、對象、地區的市場趨勢,市場規模的變化與預測,成長促進因素及阻礙因素分析,市場佔有率,競爭情形,主要企業的簡介等,全面性資訊。

內容一覽

第1章 摘要整理

第2章 調查方法

第3章 市場變數,趨勢,範圍

  • 市場區隔、範圍
  • 診斷化驗的滲透及成長預測
  • SWOT分析
  • 波特的五力分析

第4章 全球疫苗委託製造市場預測與趨勢分析:各疫苗類型

  • 各疫苗類型的市場趨勢
  • 弱毒化疫苗
  • 不活化疫苗
  • 次單元疫苗
  • 類毒素疫苗
  • DNA疫苗

第5章 全球疫苗委託製造市場預測與趨勢分析:各工作流程

  • 各工作流程的市場趨勢
  • 下游
    • 填充、最後加工
    • 分析、品管
    • 包裝
  • 上游產業
    • 哺乳動物細胞的表現系統
    • 細菌的表現系統
    • 酵母的表現系統
    • 桿狀病毒/昆蟲的表現系統
    • 其他

第6章 全球疫苗委託製造市場預測與趨勢分析:各對象

  • 各對象的市場趨勢
  • 動物

第7章 全球疫苗委託製造市場預測與趨勢分析:各地區

  • 各地區的市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 競爭情形

  • 策略架構
  • 參與企業的類別
  • 企業簡介
    • LONZA
    • FUJIFILM Diosynth Biotechnologies
    • Ajinomoto Althea, Inc.
    • Merck KGaA
    • Cytovance Biologics
    • Catalent, Inc.
    • IDT Biologika
    • Albany Molecular Research, Inc.
    • PRA Health Sciences
    • ICON plc.
    • Pharmaceutical Product Development, LLC
    • Cobra Bio
    • Paragon Bioservices, Inc.
    • KBI Biopharma
目錄
Product Code: GVR-2-68038-087-3

The global vaccine contract manufacturing market size is expected to reach USD 4.0 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a 9.3% CAGR during the forecast period. The market is anticipated to witness significant growth over the coming years thanks to rising demand for vaccine development from the private sector as well as governments in industrialized and developing countries.

Vaccine contract services offer cost-saving benefits to their clients. They also help save time in operations and management of a production and research facility. These advantages associated with Contract Manufacturing Organizations (CMOs) are expected to benefit emerging players, start-ups, and small players who lack adequate facilities and resources required for vaccine development.

Increase in pricing pressure, regulatory challenges, and patent expiration in recent times are expected to adversely impact the market. Contract services are considered "strategic competitive weapons" among vaccine manufacturers as they help overcome the aforementioned issues.

A number of international healthcare organizations are engaged in estimating and predicting the quantity of goods as well as financial need required for conducting immunization programs. Some of the factors considered for this estimation are quantity of vaccines, estimated time of delivery, product type, and vial size. Participation of international healthcare organizations in vaccination programs is expected to positively influence the growth of contract manufacturers.

Further key findings from the report suggest:

  • Contract services for development of attenuated vaccines accounted for the major share in the market based on vaccine type. This can be attributed to the fact that these vaccines offer immunity for a lifetime with only one or two doses
  • DNA vaccines form the fastest-growing segment by type, with several kinds already being tested on humans
  • Based on workflow, downstream processing dominated the market mainly due to the necessity of mature and reliable biotechnology tools for product recovery. Various research initiatives in the space are also contributing in advancing downstream workflows
  • By application, contract services for the development of human-use vaccines held the largest share owing to their high adoption to develop vaccines against influenza and other illnesses
  • Lonza; IDT Biologika GmbH; FUJIFILM Diosynth Biotechnologies U.S.A., Inc.; and Merck KGaA are some of the major players offering services for vaccine development.

Table of content

Chapter 1 Executive Summary

  • 1.1 Market Snapshot

Chapter 2 Research Methodology

  • 2.1 Information Procurement
  • 2.2 Information or Data Analysis
  • 2.3 Market Formulation & Validation

Chapter 3 Vaccine Contract Manufacturing Market Variables, Trends, & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Capacity expansion by contract manufacturers for vaccine manufacturing
      • 3.1.1.2 Global increase in vaccination coverage
      • 3.1.1.3 Vaccination innovation and robust vaccine pipeline
      • 3.1.1.4 Cost and time saving benefits offered by contract services
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Limited outsourcing by well-stablished vaccine manufacturers
  • 3.2 Penetration & Growth Prospect Mapping For Diagnostic Assays, 2016
  • 3.3 Vaccine Contract Manufacturing Market-Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4 Vaccine Contract Manufacturing Market: Vaccine Type Estimates & Trend Analysis

  • 4.1 Global Vaccine Contract Manufacturing Market: Vaccine Type Movement Analysis
  • 4.2 Attenuated Vaccine
    • 4.2.1 Global attenuated vaccine market, 2014 - 2025 (USD Million)
  • 4.3 Inactivated Vaccine
    • 4.3.1 Global inactivated vaccine market, 2014 - 2025 (USD Million)
  • 4.4 Subunit Vaccines
    • 4.4.1 Global subunit vaccines market, 2014 - 2025 (USD Million)
  • 4.5 Toxoid Vaccines
    • 4.5.1 Global toxoid vaccines market, 2014 - 2025 (USD Million)
  • 4.6 DNA Vaccines
    • 4.6.1 Global DNA vaccines market, 2014 - 2025 (USD Million)

Chapter 5 Vaccine Contract Manufacturing Market: Workflow Estimates & Trend Analysis

  • 5.1 Global Vaccine Contract Manufacturing Market: Workflow Movement Analysis
  • 5.2 Downstream
    • 5.2.1 Global downstream processing market, 2014 - 2025 (USD Million)
    • 5.2.2 Fill & Finish Operations
      • 5.2.2.1 Global fill & finish operations market, 2014 - 2025 (USD Million)
    • 5.2.3 Analytical & QC studies
      • 5.2.3.1 Global analytical & QC studies market, 2014 - 2025 (USD Million)
    • 5.2.4 Packaging
      • 5.2.4.1 Global packaging market, 2014 - 2025 (USD Million)
  • 5.3 Upstream
    • 5.3.1 Global upstream processing market, 2014 - 2025 (USD Million)
    • 5.3.2 Mammalian expression systems
      • 5.3.2.1 Global mammalian expression systems market, 2014 - 2025 (USD Million)
    • 5.3.3 Bacterial expression systems
      • 5.3.3.1 Global bacterial expression systems market, 2014 - 2025 (USD Million)
    • 5.3.4 Yeast expression systems
      • 5.3.4.1 Global yeast expression systems market, 2014 - 2025 (USD Million)
    • 5.3.5 Baculovirus/insect expression systems
      • 5.3.5.1 Global insect expression systems market, 2014 - 2025 (USD Million)
    • 5.3.6 Others
      • 5.3.6.1 Global other expression systems market, 2014 - 2025 (USD Million)

Chapter 6 Vaccine Contract Manufacturing Market: Application Estimates & Trend Analysis

  • 6.1 Global Vaccine Contract Manufacturing Market: Application Movement Analysis
  • 6.2 Human Use
    • 6.2.1 Global human use market, 2014 - 2025 (USD Million)
  • 6.3 Veterinary
    • 6.3.1 Global veterinary market, 2014 - 2025 (USD Million)

Chapter 7 Vaccine Contract Manufacturing Market: Regional Estimates & Trend Analysis, by Vaccine Type, Workflow, and Application

  • 7.1 Vaccine Contract Manufacturing Market Share By Region, 2016 & 2025
  • 7.2 North America
    • 7.2.1 North America vaccine contract manufacturing market, 2014 - 2025 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. vaccine contract manufacturing market, by vaccine type, 2014 - 2025 (USD Million)
      • 7.2.2.2 U.S. vaccine contract manufacturing market, by workflow, 2014 - 2025 (USD Million)
      • 7.2.2.3 U.S. vaccine contract manufacturing market, by application, 2014 - 2025 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada vaccine contract manufacturing market, by vaccine type, 2014 - 2025 (USD Million)
      • 7.2.3.2 Canada vaccine contract manufacturing market, by workflow, 2014 - 2025 (USD Million)
      • 7.2.3.3 Canada vaccine contract manufacturing market, by application, 2014 - 2025 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe vaccine contract manufacturing market, 2014 - 2025 (USD Million)
    • 7.3.2 Germany
      • 7.3.2.1 Germany vaccine contract manufacturing market, by vaccine type, 2014 - 2025 (USD Million)
      • 7.3.2.2 Germany vaccine contract manufacturing market, by workflow, 2014 - 2025 (USD Million)
      • 7.3.2.3 Germany vaccine contract manufacturing market, by application, 2014 - 2025 (USD Million)
    • 7.3.3 France
      • 7.3.3.1 France vaccine contract manufacturing market, by vaccine type, 2014 - 2025 (USD Million)
      • 7.3.3.2 France vaccine contract manufacturing market, by workflow, 2014 - 2025 (USD Million)
      • 7.3.3.3 France vaccine contract manufacturing market, by application, 2014 - 2025 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific vaccine contract manufacturing market, 2014 - 2025 (USD Million)
    • 7.4.2 China
      • 7.4.2.1 China vaccine contract manufacturing market, by vaccine type, 2014 - 2025 (USD Million)
      • 7.4.2.2 China vaccine contract manufacturing market, by workflow, 2014 - 2025 (USD Million)
      • 7.4.2.3 China vaccine contract manufacturing market, by application, 2014 - 2025 (USD Million)
    • 7.4.3 India
      • 7.4.3.1 India vaccine contract manufacturing market, by vaccine type, 2014 - 2025 (USD Million)
      • 7.4.3.2 India vaccine contract manufacturing market, by workflow, 2014 - 2025 (USD Million)
      • 7.4.3.3 India vaccine contract manufacturing market, by application, 2014 - 2025 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America vaccine contract manufacturing market, 2014 - 2025 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil vaccine contract manufacturing market, by vaccine type, 2014 - 2025 (USD Million)
      • 7.5.2.2 Brazil vaccine contract manufacturing market, by workflow, 2014 - 2025 (USD Million)
      • 7.5.2.3 Brazil vaccine contract manufacturing market, by application, 2014 - 2025 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA vaccine contract manufacturing market, 2014 - 2025 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa vaccine contract manufacturing market, by vaccine type, 2014 - 2025 (USD Million)
      • 7.6.2.2 South Africa vaccine contract manufacturing market, by workflow, 2014 - 2025 (USD Million)
      • 7.6.2.3 South Africa vaccine contract manufacturing market, by application, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Strategy Framework
  • 8.2 Market Participation Categorization
  • 8.3 Company Profiles
    • 8.3.1 LONZA
      • 8.3.1.1 Company overview
      • 8.3.1.2 Financial performance
      • 8.3.1.3 Product benchmarking
      • 8.3.1.4 Strategic initiatives
    • 8.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
      • 8.3.2.1 Company overview
      • 8.3.2.2 Financial performance
      • 8.3.2.3 Product benchmarking
      • 8.3.2.4 Strategic initiatives
    • 8.3.3 Ajinomoto Althea, Inc.
      • 8.3.3.1 Company overview
      • 8.3.3.2 Financial performance
      • 8.3.3.3 Product benchmarking
      • 8.3.3.4 Strategic initiatives
    • 8.3.4 Merck KGaA
      • 8.3.4.1 Company overview
      • 8.3.4.1.1 Sigma-Aldrich Co. LLC
      • 8.3.4.2 Financial performance
      • 8.3.4.3 Product benchmarking
      • 8.3.4.4 Strategic initiatives
    • 8.3.5 Cytovance Biologics
      • 8.3.5.1 Company overview
      • 8.3.5.2 Financial performance
      • 8.3.5.3 Product benchmarking
      • 8.3.5.4 Strategic initiatives
    • 8.3.6 Catalent, Inc.
      • 8.3.6.1 Company overview
      • 8.3.6.2 COOK
      • 8.3.6.2.1 Company overview
      • 8.3.6.3 Financial performance
      • 8.3.6.3.1 Financial performance
      • 8.3.6.4 Product benchmarking
      • 8.3.6.5 Strategic initiatives
    • 8.3.7 IDT Biologika
      • 8.3.7.1 Company overview
      • 8.3.7.2 Financial performance
      • 8.3.7.3 Product benchmarking
      • 8.3.7.4 Strategic initiatives
    • 8.3.8 Albany Molecular Research, Inc.
      • 8.3.8.1 Company overview
      • 8.3.8.2 OsoBio
      • 8.3.8.2.1 Company overview
      • 8.3.8.3 Financial performance
      • 8.3.8.3.1 Financial performance
      • 8.3.8.4 Product benchmarking
      • 8.3.8.5 Strategic initiatives
    • 8.3.9 PRA Health Sciences
      • 8.3.9.1 Company overview
      • 8.3.9.2 Financial performance
      • 8.3.9.3 Product benchmarking
      • 8.3.9.4 Strategic initiatives
    • 8.3.10 ICON plc.
      • 8.3.10.1 Company overview
      • 8.3.10.2 Financial performance
      • 8.3.10.3 Product benchmarking
      • 8.3.10.4 Strategic initiatives
    • 8.3.11 Pharmaceutical Product Development, LLC
      • 8.3.11.1 Company overview
      • 8.3.11.2 Financial performance
      • 8.3.11.3 Product benchmarking
      • 8.3.11.4 Strategic initiatives
    • 8.3.12 Cobra Bio
      • 8.3.12.1 Company overview
      • 8.3.12.2 Financial performance
      • 8.3.12.3 Product benchmarking
      • 8.3.12.4 Strategic initiatives
    • 8.3.13 Paragon Bioservices, Inc.
      • 8.3.13.1 Company overview
      • 8.3.13.2 Financial performance
      • 8.3.13.3 Product benchmarking
    • 8.3.14 KBI Biopharma
      • 8.3.14.1 Company overview
      • 8.3.14.2 Financial performance
      • 8.3.14.3 Product benchmarking
      • 8.3.14.4 Strategic initiatives

List of Tables

  • TABLE 1 North America vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 2 North America vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 3 North America downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 4 North America upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 5 North America vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 6 U.S. vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 7 U.S. vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 8 U.S. downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 9 U.S. upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 10 U.S. vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 11 Canada vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 12 Canada vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 13 Canada downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 14 Canada upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 15 Canada vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 16 Europe vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 17 Europe vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 18 Europe downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 19 Europe upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 20 Europe vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 21 Germany vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 22 Germany vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 23 Germany downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 24 Germany upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 25 Germany vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 26 France vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 27 France vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 28 France downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 29 France upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 30 France vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 31 Asia Pacific vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 32 Asia Pacific vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 33 Asia Pacific downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 34 Asia Pacific upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 35 Asia Pacific vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 36 China vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 37 China vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 38 China downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 39 China upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 40 China vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 41 India vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 42 India vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 43 India downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 44 India upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 45 India vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 46 Latin America vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 47 Latin America vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 48 Latin America downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 49 Latin America upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 50 Latin America vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 51 Brazil vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 52 Brazil vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 53 Brazil downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 54 Brazil upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 55 Brazil vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 56 MEA vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 57 MEA vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 58 MEA downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 59 MEA upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 60 MEA vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 61 South Africa vaccine contract manufacturing market estimates & forecasts, by vaccine type, 2014 - 2025 (USD Million)
  • TABLE 62 South Africa vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 63 South Africa downstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 64 South Africa upstream vaccine contract manufacturing market estimates & forecasts, by workflow, 2014 - 2025 (USD Million)
  • TABLE 65 South Africa vaccine contract manufacturing market estimates & forecasts, by application, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market summary
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain based sizing & forecasting
  • FIG. 7 QFD modelling for market share assessment
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Share of children immunized against Diphtheria, Tetanus, and Pertussis (DTP3)
  • FIG. 12 Infectious disease pipeline (as of April 2016)
  • FIG. 13 Market restraint relevance analysis (Current & future impact)
  • FIG. 14 Penetration & growth prospect mapping for diagnostic assays, 2016
  • FIG. 15 SWOT Analysis, By Factor (political & legal, economic, and technological)
  • FIG. 16 Porter's Five Forces Analysis
  • FIG. 17 Global vaccine contract manufacturing market: Vaccine type outlook key takeaways
  • FIG. 18 Global vaccine contract manufacturing market: Vaccine type movement analysis
  • FIG. 19 Global attenuated vaccine market, 2014 - 2025 (USD Million)
  • FIG. 20 Global inactivated vaccine market, 2014 - 2025 (USD Million)
  • FIG. 21 Global subunit vaccines market, 2014 - 2025 (USD Million)
  • FIG. 22 Global toxoid vaccines market, 2014 - 2025 (USD Million)
  • FIG. 23 Global rabies market, 2014 - 2025 (USD Million)
  • FIG. 24 Global vaccine contract manufacturing market: Workflow outlook key takeaways
  • FIG. 25 Global vaccine contract manufacturing market: Workflow movement analysis
  • FIG. 26 Global downstream processing market, 2014 - 2025 (USD Million)
  • FIG. 27 Global fill & finish operations market, 2014 - 2025 (USD Million)
  • FIG. 28 Global analytical & QC studies market, 2014 - 2025 (USD Million)
  • FIG. 29 Global packaging market, 2014 - 2025 (USD Million)
  • FIG. 30 Global upstream processing market, 2014 - 2025 (USD Million)
  • FIG. 31 Global mammalian expression systems market, 2014 - 2025 (USD Million)
  • FIG. 32 Global bacterial expression systems market, 2014 - 2025 (USD Million)
  • FIG. 33 Global yeast expression systems market, 2014 - 2025 (USD Million)
  • FIG. 34 Global insect expression systems market, 2014 - 2025 (USD Million)
  • FIG. 35 Global other expression systems market, 2014 - 2025 (USD Million)
  • FIG. 36 Global vaccine contract manufacturing market: Application outlook key takeaways
  • FIG. 37 Global vaccine contract manufacturing market: End-use movement analysis
  • FIG. 38 Global human-use market, 2014 - 2025 (USD Million)
  • FIG. 39 Global veterinary market, 2014 - 2025 (USD Million)
  • FIG. 40 Regional market place: Key takeaways
  • FIG. 41 Vaccine contract manufacturing regional outlook, 2016 & 2025
  • FIG. 42 North America vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 43 U.S. Vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 44 Canada vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 45 Europe vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 46 Germany vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 47 France vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 48 Asia Pacific vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 49 China vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 50 India vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 51 Latin America vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 52 Brazil vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 53 MEA vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 54 South Africa vaccine contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 55 Strategy framework
  • FIG. 56 Participant categorization
Back to Top